NCT05978505 - Reboxetine for Sleep Apnoea After ENT Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 10, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Sleep Apnea, Obstructive

Interventions

DRUG

Reboxetine 4 MG Oral Tablet

7 nightly doses (4mg) to commence after surgery.

DRUG

Placebo

7 nightly doses to commence after surgery.

Trial Locations (1)

RECRUITING

Flinders, Private and Public Hospitals and Flinders University, Bedford Park